Terapet SA, headquartered in Geneva, Switzerland, is a pioneering MedTech startup that emerged from CERN, the renowned European Organization for Nuclear Research. The company specializes in next-generation imaging technology designed to enhance nuclear medicine, particularly in the realms of proton therapy and nuclear imaging. Proton therapy is a type of radiation treatment that uses protons rather than X-rays to treat cancer, offering more precise targeting of tumors with less damage to surrounding healthy tissues.

Terapet's innovative platform technology aims to provide integrated imaging solutions that significantly improve the accuracy and effectiveness of proton therapy and nuclear imaging. This technology is particularly beneficial for healthcare providers and research institutions focused on precision medicine, which tailors medical treatment to the individual characteristics of each patient.

The company operates in the medical technology market, specifically targeting institutions involved in cancer treatment and medical research. Its business model revolves around the development and commercialization of advanced imaging devices and software solutions. Terapet generates revenue through the sale of these devices, as well as through partnerships and collaborations with leading research institutions and healthcare providers.

Terapet has already secured significant funding and recognition, including a CHF 100,000 FIT Tech Seed award and a CHF 50,000 grant from the Swiss BIC of CERN Technologies. The company successfully closed a seed investment round of CHF 1 million and has received over CHF 1.5 million in non-dilutive funds through various collaborations and awards. These financial milestones underscore the strong investor confidence in Terapet's potential to revolutionize the field of nuclear medicine.

In summary, Terapet SA is at the forefront of medical technology innovation, offering cutting-edge imaging solutions that enhance the precision and effectiveness of cancer treatments.

Keywords: MedTech, proton therapy, nuclear imaging, precision medicine, cancer treatment, imaging technology, healthcare innovation, CERN spin-off, medical devices, research partnerships.